{"id":"W2089449257","doi":"10.1016/j.drudis.2014.05.013","title":"Reversal of target-specific oral anticoagulants","year":2014,"lang":"en","type":"review","venue":"Drug Discovery Today","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":false,"ca_institutions":"McMaster University","funders":"National Heart, Lung, and Blood Institute","keywords":"Rivaroxaban; Edoxaban; Apixaban; Dabigatran; Medicine; Intensive care medicine; Pharmacology; Anticoagulant; Clinical trial; Warfarin; Surgery; Atrial fibrillation; Internal medicine","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004004834,0.0004119419,0.003035163,0.0002884507,0.00004382733,0.00004554594,0.0002048876,0.0001868719,0.0003541468],"category_scores_gemma":[0.0001027599,0.0002953203,0.001095769,0.0003283527,0.0000852856,0.0001850329,0.0001387635,0.0002227762,0.0003098518],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00008294986,"about_ca_system_score_gemma":0.0001490768,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001398653,"about_ca_topic_score_gemma":0.000001384632,"domain_scores_codex":[0.9977351,0.0001650104,0.0008937408,0.0004225159,0.0004450358,0.0003386429],"domain_scores_gemma":[0.9984481,0.0002170844,0.0005522112,0.0006242316,0.00004660311,0.0001117378],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001606679,0.00006347827,0.005004651,0.05363621,0.001488622,0.00007733898,0.0001203146,0.000007474075,0.000006397068,0.006711573,0.1098639,0.8228594],"study_design_scores_gemma":[0.0004978061,0.00003683355,0.0002317456,0.005537899,0.001100773,0.000007740324,0.00001614842,0.000003535707,0.000006995558,0.00004226171,0.9922377,0.0002806003],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00007174906,0.9924771,0.0002924111,0.0001623246,0.001067469,0.0009441294,0.00007291836,0.00005442192,0.004857487],"genre_scores_gemma":[0.0002561212,0.9723507,0.0004146971,0.00005092679,0.001228028,0.000003580712,0.0006158535,0.00006699901,0.02501313],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.8823738,"threshold_uncertainty_score":0.9999499,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.09173318221862578,"score_gpt":0.3735391462917583,"score_spread":0.2818059640731325,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}